US-China Trade War Hits Philips Connected Care Biz In Q3
Executive Summary
Dutch health technology giant Philips Heathcare reported weaker than expected Q3 results. Sales remained in line with expectations with a 6% increase to €4.7bn ($5.2bn) in the quarter but adjusted EBITA margin was down, due to US-China tariffs impacting the company’s connected care division.
You may also be interested in...
Qiagen’s Ambitions: Standing Alone And Strengthening Infectious Disease Portfolio
Qiagen official Antoine Marchal outlines how NeuModx will strengthen its position in the infectious disease space.
Angle Files De Novo Submission For Parsortix System In Breast Cancer
The system has the potential to be the first FDA-cleared device for harvesting intact cancer cells from a blood sample for subsequent analysis.
Abbott Surprises Analysts With CE Mark For Freestyle Libre 3
The new continuous glucose sensor is the smallest and thinnest in the world, according to Abbott.